Aurobindo Pharma Buyback Record Date is 30 July 2024.Â
Aurobindo Pharma is a leading Indian pharmaceutical company founded in 1986. Aurobindo manufactures and markets generic pharmaceuticals and active pharmaceutical ingredients (APIs) across major therapeutic areas such as antibiotics, antiretrovirals, central nervous system, cardiovascular, anti-diabetics, and more.
The company has a large diversified product portfolio with over 870 marketed drugs and a strong global presence, exporting to over 150 countries. Aurobindo operates state-of-the-art manufacturing facilities approved by leading regulatory bodies like the US FDA, UK MHRA, TGA Australia, and EMA, as well as R&D centers leveraging a team of over 1,700 expert scientists and analysts globally.
Aurobindo Pharma Buyback Record Date, Other Details
| Aurobindo Pharma Buyback Dates | 5 – 9 August 2024 |
| Aurobindo Pharma Buyback Price | INR 1,460 per share |
| Market Price on Buyback Approval | INR 1,330 per share |
| Buyback Premium on Market Price | 9.77% |
| Buyback Offer Size (Shares) | 51,36,986 shares |
| Buyback Offer Size (Amount) | INR 750 crore |
| Offer Type | Tender |
| Promoter Participation | Yes |
| Face Value | INR 1 per share |
| Listing At | BSE, NSE |
Aurobindo Pharma Buyback Dates (Timeline)
| Board Meeting Intimation for Buyback Proposal | 14 July 2024 |
| Buyback Approval Date | 18 July 2024 |
| Public Announcement of Buyback | 22 July 2024 |
| Aurobindo Pharma Buyback Record Date | 30 July 2024 |
| Buyback Opening Date | 5 August 2024 |
| Buyback Closing Date | 9 August 2024 |
| Cut-off Date to receive completed tender forms by Registrar | 9 August 2024 |
| Verification Date by the Registrar | 14 August 2024 |
| Return of unaccepted shares by Registrar | 19 August 2024 |
| Extinguishment of accepted shares | 28 August 2024 |
Aurobindo Pharma Buyback 2024 Documents
Letter of Offer
Public Announcement
Board Approval
Upcoming Share Buyback
Aurobindo Pharma Buyback Entitlement Ratio
| Shareholder Category | Entitlement Ratio | Entitlement Ratio (in %) |
| Small Shareholders (less than INR 2 Lakh on record date) | 5/41 | 12.20 |
| General category (for all other Eligible Shareholders) | 4/531 | 0.75 |
A small shareholder is defined as a shareholder who holds shares worth less than INR 2,00,000 as of the record date.
Aurobindo Pharma Financial Performance
| FY 2022 | FY 2023 | FY 2024 | |
| Total Income | 23,455 | 24,855 | 29,002 |
| Total Expenses | 19,060 | 21,148 | 23,176 |
| Net Income | 2,647 | 1,928 | 3,169 |
Calculation of Investment in Buyback
| Maximum market value of a shareholder as on record date | INR 2,00,000 |
| Buyback price per share | INR 1,460 |
| Maximum shares for small shareholders (2,00,000/1,460) | 137 shares * |
| The closing price of the stock as of 18 July 2024 | INR 1,330** |
| Maximum amount invested in buyback (INR 1,330 x 137 shares) | INR 1,82,210 |
**Â For simplicity, we have considered the price on the buyback approval date
Aurobindo Pharma Buyback Acceptance Ratio
| Shares Tendered | Buyback Entitlement | Acceptance ratio | Buyback Profit | Profit in % |
| 137 | 17 | 17 (100%) | 2,210 | 1.21 |
| 137 | 17 | 34 (200%) | 4,420 | 2.43 |
| 137 | 17 | 51 (300%) | 6,630 | 3.64 |
Registrar of Aurobindo Pharma Buyback 2024
KFIN TECHNOLOGIES LIMITED
Selenium Tower – B, Plot 31 & 32, Gachibowli,
Financial District, Nanakramguda, Serilingampally,
Hyderabad – 500 032, Telangana
Tel:Â +91 40 6716 2222
E-mail:Â [email protected]
Website:Â www.kfintech.com
Manager of Aurobindo Pharma Buyback 2024
AXIS CAPITAL LIMITED
1st floor, Axis House, C-2 Wadia International Centre,
P.B. Marg, Worli, Mumbai – 400025
Tel:Â +91 22 4325 2183
E-mail:Â [email protected]
Website:Â www.axiscapital.co.in
The Process to Participate in Aurobindo Pharma Buyback
All eligible shareholders of the company who own shares in the physical or demat form on the record date may participate in the buyback offer through their stockbroker. The eligible shareholders who hold the shares in demat form must notify their brokers of the details of the equity shares that they wish to tender in the buyback offer.
The shareholder must transfer the tendered shares to the clearing corporation’s Special account. In turn, the broker would place a buyback order on the stock exchange.
The eligible shareholders who own the shares in physical form must present their broker with the original share certificates and supporting documents. After document verification is complete, the broker places an order on the stock exchange and submits the original share certificate and TRS (Transaction Registration Slip) to the registrar.
Frequently Asked Questions
What are Aurobindo Pharma buyback dates?
Aurobindo Pharma’s share buyback opens on 5 August 2024 and closes on 9 August 2024.
Which type of buyback is Aurobindo Pharma buyback offer?
Aurobindo Pharma’s buyback is a tender offer.
What is Aurobindo Pharma buyback price?
Aurobindo Pharma buyback price is INR 1,460 per share.
What is the Aurobindo Pharma buyback record date?
Aurobindo Pharma buyback record date is 30 July 2024.
How to participate in Aurobindo Pharma share buyback?
Aurobindo Pharma’s share buyback will be conducted through the tender process and investors who hold the shares on record date can place orders through their broker.
